This Exhibitor Product Theater is a promotional activity and is not approved for continuing education credit. The content of this Exhibitor Product Theater and opinions expressed by presenters are those of the sponsor or presenter and are not of the San Antonio Breast Cancer Symposium (SABCS).
Featured
Redefining Possibilities in HER2-Expressing mBC Care
Exhibit Hall, Product Theater B
Sponsored by Daiichi Sankyo, Inc. and AstraZeneca
Medical Crossfire® The Who, When, and How of TROP2-Targeting ADCs, ICIs, and PARP inhibition in Triple-Negative Breast Cancer
Grand Ballroom Salons CDE
These symposia are sponsored by PER and supported by grants from AstraZeneca; Daiichi Sankyo, Inc; Merck Sharp & Dohme Corp; and Pfizer, Inc. This is not an official program of the San Antonio Breast Cancer Symposium.
